Edwards Group | Bone Oncology
We aim to identify the mechanisms contributing to bone disease caused by cancer and develop new treatments for these conditions.
Metastasis of cancers to bone
Cancer-induced bone disease is a characteristic feature of several types of cancer, including the hematological malignancy multiple myeloma, and other tumours that metastasise to bone such as breast, prostate and lung. In addition to the development of debilitating skeletal complications, the bone marrow provides a unique hospitable microenvironment, and once tumours become established in bone, they are largely unresponsive to treatment.
The overall goal of our research is to elucidate the cellular and molecular mechanisms that contribute to disease pathogenesis, and so identify and validate novel therapeutic approaches. Our focus is on the role of the tumour microenvironment and tumour-host interactions.
Major ThemeS
- Obesity, adipocytes and adipokines in tumour growth and cancer-induced bone disease
- Aging, senescence and dormancy in the tumour-bone microenvironment
- Metabolism in the prostate cancer-bone microenvironment
- Using microfluidics to study the tumour-bone microenvironment
- Circulating tumour cells in prostate cancer bone metastasis.
Collaborators
- Professor Freddie Hamdy
- Professor James Edwards
- Dr Srinivasa Rao
- Professor Ian Mills
- Dr Ed O'Neill
- Professor Edmond Walsh
- Professor Colin Goding
- Professor Jason Davis
- Professor Alastair Lamb
- Professor Udo Oppermann
- Professor Adam Cribbs
- Professor Katja Simon
- Professor Ester Hammond
- Professor John Christianson
- Dr Sarah Gooding
- Dr Karthik Ramasamy
- Professor Peter Cook
- Professor Chris Bunce (University of Birmingham)
- Dr Michelle Lawson (University of Sheffield)
- Professor Nikki Horwood (UEA)
Latest publications
ssociation between deep cervical lymph node dissection and dementia incidence in patients with head and neck cancer: a systematic review
Journal article
Omar M. et al, (2026), European Journal of Plastic Surgery, 49
Resilience Engineering concepts, Safety-II language, FRAM practice, and co-creating communities: how Hollnagel reshaped patient safety
Journal article
Sujan M. et al, (2026), Safety Science, 200
KLRG1 identifies circulating cytotoxic CD4 T cells with selective anti-tumor function in human cancer
Preprint
Cenerenti M. et al, (2026)
Pathological cortico-STN beta coupling in Parkinson's disease is confined to beta bursts
Preprint
Beaudoin CA. et al, (2026)